Physician profile
Khase A Wilkinson
NPI 1235139551
$10,436.82
in general payments reported to CMS, 2019-2025
27 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what 86% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $76.73 · 2021: $886 · 2022: $3,380 · 2023: $1,719 · 2024: $2,667 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,793 · Travel and Lodging: $2,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,793.24 |
| Travel and Lodging | $2,087.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,617.86 | 2021-2025 | Citrefix, Variax, Augment Injectable |
| Orthofix Medical, INC. | $1,627.38 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,450.26 | 2024 | |
| Integra Lifesciences Corporation | $934.00 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Rock Medical Orthopedics, INC. | $841.18 | 2021-2024 | |
| Depuy Synthes Sales INC. | $584.19 | 2019-2025 | Hammerlock, Crosstie, Na |
| Organogenesis INC. | $317.31 | 2019-2025 | Puraply, Puraply Wound Matrix, Puraply Antimicrobial |
| Arthrex, INC. | $278.08 | 2023 | |
| Treace Medical Concepts, INC. | $275.39 | 2025 | |
| Medtronic, INC. | $274.15 | 2024 | In.Pact Admiral |
| Smith+Nephew, INC. | $238.93 | 2021-2025 | Grafix Pl, Grafix, Panta 2 |
| Kerecis Limited | $204.37 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paragon 28, INC. | $162.85 | 2020-2024 | Additive Orthopedics, Ankle Fracture, Calc Slide |
| Abbott Laboratories | $131.46 | 2024 | Proclaim |
| Janssen Pharmaceuticals, INC | $98.51 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $90.52 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $51.94 | 2024-2025 | Nuzyra |
| Medtronic USA, INC. | $50.63 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $44.75 | 2021-2022 | |
| Nexus Medical Technologies LLC | $33.02 | 2024-2025 | |
| Kci USA, INC. | $22.80 | 2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice, Prevena Restor Axioform |
| Grt US Holding, INC. | $21.00 | 2022 | |
| Averitas Pharma INC. | $20.31 | 2025 | Qutenza |
| Solventum Corporation | $19.08 | 2024 | Activ.A.C. |
| Urgo Medical North America, LLC | $16.86 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Avanos Medical | $15.59 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.40 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khase Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.